These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 17703532

  • 1. Antiretroviral drugs and the risk of myocardial infarction.
    Zangerle R, Sarcletti M.
    N Engl J Med; 2007 Aug 16; 357(7):715-6; author reply 716-7. PubMed ID: 17703532
    [No Abstract] [Full Text] [Related]

  • 2. Antiretroviral drugs and the risk of myocardial infarction.
    Kaplan RC, Tien PC, Lazar J.
    N Engl J Med; 2007 Aug 16; 357(7):715; author reply 716-7. PubMed ID: 17699825
    [No Abstract] [Full Text] [Related]

  • 3. Class of antiretroviral drugs and the risk of myocardial infarction.
    DAD Study GroupUniversity of Copenhagen, Copenhagen, Denmark., Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.
    N Engl J Med; 2007 Apr 26; 356(17):1723-35. PubMed ID: 17460226
    [Abstract] [Full Text] [Related]

  • 4. Antiretroviral drugs and the risk of myocardial infarction.
    Pollack TM, Rind DM.
    N Engl J Med; 2007 Aug 16; 357(7):716; author reply 716-7. PubMed ID: 17703531
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular risks of antiretroviral therapy.
    Stein JH.
    N Engl J Med; 2007 Apr 26; 356(17):1773-5. PubMed ID: 17460232
    [No Abstract] [Full Text] [Related]

  • 6. '96-'97 new drugs and the nominees for 1997 are...
    Notes Undergr; 1997 Apr 26; (No 35):suppl 1-2. PubMed ID: 11364566
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.
    Tordato F, Cozzi Lepri A, Cicconi P, De Luca A, Antinori A, Colangeli V, Castagna A, Nasta P, Ladisa N, Giacometti A, d'Arminio Monforte A, Gori A, ICONA Foundation Study Group.
    HIV Med; 2011 Jan 26; 12(1):4-13. PubMed ID: 20584091
    [Abstract] [Full Text] [Related]

  • 8. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.
    AIDS; 2008 Jul 11; 22(11):1305-12. PubMed ID: 18580610
    [Abstract] [Full Text] [Related]

  • 9. Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects.
    Smith RJ, Wahl LM.
    Bull Math Biol; 2004 Sep 11; 66(5):1259-83. PubMed ID: 15294425
    [Abstract] [Full Text] [Related]

  • 10. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
    Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL, Katlama C, Costagliola D, ANRS 121 Hippocampe study group.
    AIDS; 2009 Apr 27; 23(7):817-24. PubMed ID: 19363330
    [Abstract] [Full Text] [Related]

  • 11. [Myocardial infarction in the course of antiretroviral therapy with protease inhibitor].
    Buccoliero G, Lonero G, Rollo MA, Cristiano L, Romanelli C, Loperfido P, Chimienti A, Angelini P, Resta F.
    Recenti Prog Med; 2003 Jun 27; 94(6):264-6. PubMed ID: 12793098
    [Abstract] [Full Text] [Related]

  • 12. [Antiretroviral treatment for HIV and adipose tissue].
    Caron M, Bastard JP, Auclair M, Vigouroux C, Capeau J.
    Journ Annu Diabetol Hotel Dieu; 2003 Jun 27; ():147-58. PubMed ID: 12868307
    [No Abstract] [Full Text] [Related]

  • 13. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
    Mannheimer SB, Wold N, Gardner EM, Telzak EE, Huppler Hullsiek K, Chesney M, Wu AW, MacArthur RD, Matts J, Friedland G, Terry Beirn Community Programs for Clinical Research on AIDS.
    Clin Infect Dis; 2008 Mar 15; 46(6):941-5. PubMed ID: 18279044
    [Abstract] [Full Text] [Related]

  • 14. No nukes please.
    TreatmentUpdate; 2002 Nov 15; 14(8):6. PubMed ID: 12501825
    [No Abstract] [Full Text] [Related]

  • 15. Focus on fat.
    TreatmentUpdate; 2002 Nov 15; 14(8):4. PubMed ID: 12501822
    [No Abstract] [Full Text] [Related]

  • 16. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
    Ananworanich J, Gayet-Ageron A, Ruxrungtham K, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, LeBraz M, Jupimai T, Ubolyam S, Schutz M, Hirschel B, Staccato Thailand Study Group.
    Antivir Ther; 2008 Nov 15; 13(3):375-80. PubMed ID: 18572750
    [Abstract] [Full Text] [Related]

  • 17. [Myocardial infarct with protease inhibitors: a case report].
    Lardeur JY, Remblier C, Viel S, Raud-Raynier P, Sosner P, Walter M, Baudier D, Perault-Pochat MC.
    Therapie; 2002 Nov 15; 57(3):311-3. PubMed ID: 12422549
    [No Abstract] [Full Text] [Related]

  • 18. Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).
    Guiguet M, Mary-Krause M, Ename B, Costagliola D, Grabar S.
    Pharmacoepidemiol Drug Saf; 2008 May 15; 17(5):468-74. PubMed ID: 18324608
    [Abstract] [Full Text] [Related]

  • 19. Trends in rates of myocardial infarction among patients with HIV.
    Holmberg SD, Moorman AC, Greenberg AE.
    N Engl J Med; 2004 Feb 12; 350(7):730-2; author reply 730-2. PubMed ID: 14960752
    [No Abstract] [Full Text] [Related]

  • 20. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY, Diallo K, Adje-Toure C, Chorba T, Nkengasong JN.
    J Clin Virol; 2009 May 12; 45(1):72-5. PubMed ID: 19375979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.